-
Autoimmune encephalitis: signs and symptoms, etiology, epidemiology, diagnosis and treatment
Time of Update: 2022-09-06
Diagnostic conditions include four aspects: clinical manifestations, auxiliary examinations, confirmatory tests, and exclusion of other causes.
Diagnostic conditions include four aspects: clinical manifestations, auxiliary examinations, confirmatory tests, and exclusion of other causes.
Diagnostic conditions include four aspects: clinical manifestations, auxiliary examinations, confirmatory tests, and exclusion of other causes.
-
PNAS: Plasmids can spread between different bacterial 'communities
Time of Update: 2022-08-10
"Fitness effects of plasmids shape the structure of bacteria–plasmid interaction networks DNA molecules called plasmids, some of which protect bacteria from antibiotics, can spread rapidly through bacterial "colonies" treated with antibiotics, a new study shows .
-
Tengshengbo drug BRII-179 was used for the functional cure of hepatitis B in phase 2a/2b clinical completion of the first subject administration
Time of Update: 2022-01-10
HK), a multinational company dedicated to the development of innovative therapies for patients’ unmet needs and major public health diseases, today announced that BRII-179 (VBI-2601) treats chronic hepatitis B virus (HBV) infection Phase 2a/2b clinical trials have completed the first subject's administration .
-
Brain: What are the neuropathological lesions of COVID-19
Time of Update: 2021-11-12
Neuropathological examination of 20-30 regions of each brain showed that all brains have hypoxic/ischemic changes, including whole brain and focal; large and small infarcts, many of which have hemorrhage; microglia activation With microglia nodules and neuronal phagocytosis, it is most obvious in the brainstem .
-
Physical and chemical properties and uses of tetracyclines
Time of Update: 2021-09-19
TCs mainly bind to the 30S small subunit, which interferes with the binding of the amino acid tRNA and the 30S small subunit, so that the aminoacyl tRNA cannot enter the receptor site on the mRNA and inhibits peptide chain elongation during protein synthesis .
-
Infectious disease expert: anthrax is rarely transmitted from person to person, scientific prevention is the key
Time of Update: 2021-09-10
Mao Xiaorong believes that irregular livestock vaccination, non-strict quarantine and unscientific slaughter methods may be the main causes of anthrax infection .
"Of the cases discovered so far, most of the people infected with anthrax are herders or people who are engaged in breeding and slaughtering cattle, sheep and livestock and selling related products.
-
Neurology: During the COVID-19 pandemic, the number of hospitalizations and thrombolytic treatments for stroke globally decreased significantly
Time of Update: 2021-04-14
The COVID-19 pandemic is related to the overall decline in stroke hospitalization and IVT treatment.
The COVID-19 pandemic is related to the overall decline in stroke hospitalization and IVT treatment.
0000000000011885" target="_blank" rel="noopener">Global Impact of COVID-19 on Stroke Care and Intravenous Thrombolysis neurology.
-
Noninvasive Bioluminescent Imaging of Infections
Time of Update: 2021-02-28
This technology do not requires the sacrifice of the experimental animals, where the in vivo bioluminescence emissions in living animals permit the tracking of the infection.
-
Modelling the Onset of Virulence in Pathogenic Bacteria
Time of Update: 2021-02-22
Bacterial virulence is a multifactorial process.
In this chapter, we review some known mechanisms used by bacteria to trigger their production of virulence factors.
We conclude that in most cases a “successful” infection would require that the onset of virulence follows an irreversible switch behaviour.
-
General Administration of Food and Drug Administration: 9 batches of Chinese medicine tablets were detected carcinogens
Time of Update: 2021-02-07
the above-mentioned non-conforming Chinese medicine tablets, the relevant provincial (city) Food and Drug Administration has taken seizure and other control measures, requiring enterprises to suspend the sale of the use, recall products, and carry out rectification.
-
Cell: Don't do it, eat it and get sick? Cell reveals the theoretical basis behind the implant resistance of the microbiome
Time of Update: 2021-01-31
Recently, a team of researchers from the National Institutes of Health published a study in Cell entitled Input trains for microbiota-enhanced resistance to pathogens, which found that intestinal pathogenic bacterial infections can "train" the host's bile acid metabolism and the increase of taurine in the intestines of its products, which can be catalyticized by bacteria of taurine to inhibit the respiratory action of pathogenic bacteria and enhance the phytosinosis.
-
CELL: COVID-19 Medium Antibodies predict the life and death of patients
Time of Update: 2020-12-24
Recently, researchers examined antibody responses in 113 COVID-19 patients and found that severe cases leading to intumping or death showed increased signs of inflammation, decreased lymphocytes, inflammatory cytokines, and high levels of anti-RBD antibodies.
-
J Clin Invest: Changes in anti-SARS-CoV-2 levels and antibody levels and related factors during the recovery period in patients with neo-coronary pneumonia
Time of Update: 2020-12-24
SARS-CoV-2-specific antibodies can prevent re-infection and disease, providing a theoretical basis for the use of plasma containing SARS-CoV-2 neutral antibodies (nAb) to treat neo crown pneumonia.
the study tested serum anti-SARS-CoV-2 hedgehog protein S1 domain IgG, nucleoprotein (NP) and nAb on recovery blood donors with SARS-CoV-2 infection.
-
China's State Drug Administration has approved a Phase I/II clinical trial of ATG-016 (Eltanexor) to treat high-risk bone marrow growth syndrome
Time of Update: 2020-12-16
recently, China's State Drug Administration (NMPA) has approved a clinical trial of ATG-016 (eltanexor) for the treatment of high-risk bone marrow growth syndrome (MDS).
, the ATG-016 has blood-brain barrier permeability compared to the first generation of SINE, which shows initial anti-cancer activity in patients with high-risk MDS.
-
"Pharmaceutical Express" AstraZeneta's new crown vaccine side effects Saisheng Pharmaceuticals filed for an IPO
Time of Update: 2020-11-14
(Pharmaceutical Rubik's Cube) Bayer P2X3 antagonist was approved in China for the first time clinical CDE latest publicity, Bayer recently declared a new class 1 drug BAY1817080 was approved in China for the first time clinical, adaptive disorders are: treatment of difficult to treat and/or unexplained chronic cough.
